A PDK-1 allosteric agonist improves spatial learning and memory in a ?APP/PS-1 transgenic mouse-high fat diet intervention model of Alzheimer?s disease

被引:6
作者
Querfurth, Henry [1 ]
Slitt, Angela [2 ]
DiCamillo, Amy [3 ]
Surles, Nathan [3 ]
DeBoef, Brenton [4 ]
Lee, Han-Kyu [5 ]
机构
[1] Tufts Univ, Dept Neurol, Tufts Med Ctr & Neurosci, 800 Washington, St Boston, MA 02111 USA
[2] Univ Rhode Island, Dept Biomed & Pharmaceut Sci, 7 Greenhouse Rd, Kingston, RI 02881 USA
[3] Melior Discovery Inc, 860 Springdale Dr Suite 500, Exton, PA 19341 USA
[4] Univ Rhode Island, Dept Chem, 7 Greenhouse Rd, Kingston, RI 02881 USA
[5] Tufts Med Ctr, Dept Neurol, 800 Washington, St Boston, MA 02111 USA
关键词
Alzheimer ?s disease; Insulin resistance; Transgenic mice; PDK-1; agonist; Memory; Morris water maze; GAMMA-SECRETASE MODULATOR; BETA-AMYLOID ACCUMULATION; BRAIN INSULIN-RESISTANCE; A-BETA; COGNITIVE DEFICITS; SYNAPTIC PLASTICITY; TOLFENAMIC ACID; IN-VIVO; RISK; PATHOLOGY;
D O I
10.1016/j.bbr.2022.114183
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Diabetes mellitus (DM), peripheral insulin resistance (IR) and obesity are clear risk factors for Alzheimer's disease. Several anti-diabetic drugs and insulin have been tested in rodents and humans with MCI or AD, yielding promising but inconclusive results. The PDK-1/Akt axis, essential to the action of insulin, has not however been pharmacologically interrogated to a similar degree. Our previous cell culture and in vitro studies point to such an approach. Double transgenic APPsw/PSENdE9 mice, a model for Alzheimer's disease, were used to test the oral administration of PS48, a PDK-1 agonist, on preventing the expected decline in learning and memory in the Morris Water Maze (MWM). Mice were raised on either standard (SD) or high fat (HFD) diets, dosed beginning 10 months age and tested at an advanced age of 14 months.PS48 had positive effects on learning the spatial location of a hidden platform in the TG animals, on either SD or HFD, compared to vehicle diet and WT animals. On several measures of spatial memory following successful acquisition (probe trials), the drug also proved significantly beneficial to animals on either diet. The PS48 treatment-effect size was more pronounced in the TG animals on HFD compared to on SD in several of the probe measures. HFD produced some of the intended metabolic effects of weight gain and hyperglycemia, as well as accelerating cognitive impairment in the TG animals. PS48 was found to have added value in modestly reducing body weights and improving OGTT responses in TG groups although results were not definitive. PS48 was well tolerated without obvious clinical signs or symptoms and did not itself affect longevity. These results recommend a larger preclinical study before human trial.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] A longitudinal assessment of retinal function and structure in the APP/PS1 transgenic mouse model of Alzheimer’s disease
    Dana Georgevsky
    Stephanie Retsas
    Newsha Raoufi
    Olga Shimoni
    S. Mojtaba Golzan
    Translational Neurodegeneration, 8
  • [32] A longitudinal assessment of retinal function and structure in the APP/PS1 transgenic mouse model of Alzheimer's disease
    Georgevsky, Dana
    Retsas, Stephanie
    Raoufi, Newsha
    Shimoni, Olga
    Golzan, S. Mojtaba
    TRANSLATIONAL NEURODEGENERATION, 2019, 8 (01)
  • [33] The role of neuroinflammation and amyloid in cognitive impairment in an APP/PS1 transgenic mouse model of Alzheimer's disease
    Zhu, Shenghua
    Wang, Junhui
    Zhang, Yanbo
    He, Jue
    Kong, Jiming
    Wang, Jun-Feng
    Li, Xin-Min
    CNS NEUROSCIENCE & THERAPEUTICS, 2017, 23 (04) : 310 - 320
  • [34] Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease
    Lok, Kenghoe
    Zhao, Hong
    Zhang, Can
    He, Na
    Shen, Hanlin
    Wang, Zejian
    Zhao, Wenjuan
    Yin, Ming
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2013, 335 (1-2) : 145 - 154
  • [35] Olfactory dysfunction in the APP/PS1 transgenic mouse model of Alzheimer's disease: Morphological evaluations from the nose to the brain
    Yao, Zhi-Gang
    Hua, Fang
    Zhang, Hao-Zhuang
    Li, Yan-Yan
    Qin, Ye-Jun
    NEUROPATHOLOGY, 2017, 37 (06) : 485 - 494
  • [36] Longitudinal assessment of peripheral organ metabolism and the gut microbiota in an APP/PS1 transgenic mouse model of Alzheimer's disease
    Li, Hongli
    Huang, Jianhua
    Zhao, Di
    Zhu, Lemei
    Zhang, Zheyu
    Yi, Min
    Peng, Weijun
    NEURAL REGENERATION RESEARCH, 2025, 20 (10) : 2982 - 2997
  • [37] Increased Hippocampal Neurogenesis in the Progressive Stage of Alzheimer's Disease Phenotype in an APP/PS1 Double Transgenic Mouse Model
    Yu, Yingxin
    He, Jue
    Zhang, Yanbo
    Luo, Huanmin
    Zhu, Shenghua
    Yang, Yi
    Zhao, Tou
    Wu, Jiang
    Huang, Yuangui
    Kong, Jiming
    Tan, Qingrong
    Li, Xin-Min
    HIPPOCAMPUS, 2009, 19 (12) : 1247 - 1253
  • [38] Subchronic memantine administration on spatial learning, exploratory activity, and nest-building in an APP/PS1 mouse model of Alzheimer's disease
    Filali, Mohammed
    Lalonde, Robert
    Rivest, Serge
    NEUROPHARMACOLOGY, 2011, 60 (06) : 930 - 936
  • [39] Evaluation of Neuropathological Effects of a High-Fat Diet in a Presymptomatic Alzheimer's Disease Stage in APP/PS1 Mice
    Ettcheto, Miren
    Petrov, Dmitry
    Pedros, Ignacio
    Alva, Norma
    Carbonell, Teresa
    Beas-Zarate, Carlos
    Pallas, Merce
    Auladell, Carme
    Folch, Jaume
    Camins, Antoni
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 54 (01) : 233 - 251
  • [40] Dietary Supplementation of Walnuts Improves Memory Deficits and Learning Skills in Transgenic Mouse Model of Alzheimer's Disease
    Muthaiyah, Balu
    Essa, Musthafa M.
    Lee, Moon
    Chauhan, Ved
    Kaur, Kulbir
    Chauhan, Abha
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 42 (04) : 1397 - 1405